Enzon Pharmaceuticals
(OTC) ENZN
Enzon Pharmaceuticals Financials at a Glance
Market Cap
$4.45M
Revenue (TTM)
$0.00
Net Income (TTM)
$3.41M
EPS (TTM)
$-0.07
P/E Ratio
-0.80
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$0.06
Volume
70,787
Open
$0.05
Price
$0.06
Volume
70,787
Open
$0.05
Previous Close
$0.06
Daily Range
$0.05 - $0.07
52-Week Range
$0.01 - $0.13
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$0.06
Volume
70,787
Open
$0.05
Previous Close
$0.06
Daily Range
$0.05 - $0.07
52-Week Range
$0.01 - $0.13
ENZN News
ENZN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Enzon Pharmaceuticals
Industry
Biotechnology
Sector
Health CareCEO
Richard L. Feinstein, CPA
Website
www.enzon.comHeadquarters
Cranford, NJ 07016, US
ENZN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-8%
Return on Capital
-3%
Return on Assets
-8%
Earnings Yield
-1.25%
Dividend Yield
0.00%
Payout Ratio
-37.40%
Stock Overview
Market Cap
$4.45M
Shares Outstanding
74.21M
Volume
70.79K
Short Interest
0.00%
Avg. Volume
72.86K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.36M
EBITDA
$1.36M
Operating Cash Flow
$3.01M
Capital Expenditure
$0.00
Free Cash Flow
$3.01M
Cash & ST Invst.
$42.57M
Total Debt
$0.00
Enzon Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.45M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$1.07M
-1387.5%
EBITDA
$318.00K
N/A
Quarterly Fundamentals
Net Cash
$42.57M
-9.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-7.96%
N/A
Return on Invested Capital
-3.22%
N/A
Free Cash Flow
$682.00K
-401.8%
Operating Cash Flow
$682.00K
-401.8%